0% found this document useful (0 votes)
16 views2 pages

The General Manager Pakistan Stock Exchange Building Stock Exchange Road Karachi

Citi Pharma Limited's Board of Directors approved the financial statements for the half year ended December 31, 2024, reporting no cash dividends, bonus shares, or other entitlements. The company achieved net sales of approximately 6.76 billion Rupees, with a profit after tax of around 458.47 million Rupees. The earnings per share for the period were reported at 2.01.

Uploaded by

sbinkhalid1691
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
16 views2 pages

The General Manager Pakistan Stock Exchange Building Stock Exchange Road Karachi

Citi Pharma Limited's Board of Directors approved the financial statements for the half year ended December 31, 2024, reporting no cash dividends, bonus shares, or other entitlements. The company achieved net sales of approximately 6.76 billion Rupees, with a profit after tax of around 458.47 million Rupees. The earnings per share for the period were reported at 2.01.

Uploaded by

sbinkhalid1691
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

Citi Pharma Limited

February28, 2025

The General Manager


Pakistan Stock ExchangeLimited
Stock Exchange Building
Stock Exchange Road
Karachi.
Financial results for the half year ended December 31, 2024
Dear Sir,

We have to inform you that the Board of Directorsof the company in their meeting held on February 28,
2025 at Lahore have approved the financial statements for the half year ended on December 31, 2024 and
recommendedthe following.

CashDividend Nil
Bonus Shares Nil
Right Shares Nil
Any other entitlement/corporate action Nil
Any other Price sensitive information Nil

FinancialPerformance:
While reviewing the Company financial performance for the half year ended, the Board appreciated the
efforts of the management in the areaof operation and posting the financial results.

Financialresults of the companyfor the half year ended December 31, 2024 are enclosed.

Half Yearly report of the Company for the period ended December 31, 2024 will be transmitted through
PUCARS separately, within the specified time.
(-
Yours Sin£QeJy,

or?S .
ainf#'p&;geer
CompaTy Secretary

Cc
ExecutiveDirector/HOD, Offsite-II, Department
Supervision Division, Securities & ExchangeCommissionof Pakistan

Eh 588- Q, JoharTown,Lahore- Pakisatn ”;a [Link] Road,Phool Nagar,District Kasur - Pakistan

; HeadOffice : +92.42. 35316587- 90 1 Factory: +92.49. 4510189,+92.49. 4513392 [Link]


Citi Pharma Limited
CITI PHARMA LIMITED
CONDENSED INTERIM STATEMENT OF PROFIT ORLOSS (UN-AUDITED)
FOR THEHALF YEAR ENDED DECEMBER 31, 2024

Three month ended Six Month Ended

December31, 2024 December31, 2023 December31, 2024 December31, 2023


Notes --.–--–---–––-–-––––-–-––––Rupees–---'-'--'-'-'---------------'--------------

Sales-Net 3,534,432,320 3,275,164,830 6,759,077,137 5,976,393,097

Costof Sales .(2,995,298,6291 (2,649,999,438) (5,791,430,427) (5,104,759,709)


Gross Profit 539, 133,691 625,165,392 967,646,710 871, 633, 388

Administrative Expenses 51,252,284 104,646,213


31,504,344 83,827,444
Selling Expenses
(101,381,207) (82,756,628) (188,473,657) (169,653,233)

OperatingProfit 437, 752,484 542,408,764 779, 173,053 701, 980, 155

Financial(Cost) /Income (67,868,191) (70,165,726) 132,441,809)


( (156,974,215)
369,884,293 472,243,038 646,731,244 545,005, 940

Other Income/(Loss) 13 50,423,119 157,403,690 142.644,938 263.611.872


420,307,412 629,646,728 789,376, 182 808, 617, 812

Other Expenses (26,133,137) (43,148,644) (54,904,003) (55,493,379)

profit knforeinc©ww taxesand final taxes 394, 174,275 586,498,084 734,472, 179 753, 124,433

Taxation - Final taxes


(255,267) (4,004) (255,267)

Profit tnfore income tax 394, 174,275 586,242,817 752,869, 166


734,468, 175

Taxation - Income tax (137,195,683) (210,642,174) (275,996,570) (282,816,983)

profit aher irlcaIrn tax 256,978,592 375,600,644 458,471,605 470,052, 183

Earnings per share (EPS)


- Basic andDiluted 1.12 1.64 2.01 2.06

Eh 588- Q, johar Town,Lahore- Pakisatn - = = [Link] Roadl Phool Nagarl District Kasur _ Pakistan

-{; HeadOffice : +92.42. 35316587- 90 ! Factory: +92.49. 4510189,+92.49. 4513392 [Link]

You might also like